Literature DB >> 16035619

Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells.

Xiaoping Duan1, Shu-Fang Jia, Zhichao Zhou, Robert R Langley, Marcela F Bolontrade, Eugenie S Kleinerman.   

Abstract

INTRODUCTION: Expression of adhesion molecules such as alphavbeta3 integrin has been associated with the metastatic potential of tumor cells. The purpose of this study was to determine whether alphavbeta3 expression correlated with the metastatic potential of human osteosarcoma cells.
MATERIALS AND METHODS: We developed a series of sublines (LM2-LM7) from human osteosarcoma SAOS parental cells, with progressively increasing potential to form lung metastases in nude mice after intravenous injection. SAOS parental and LM2 cells were poorly metastatic, but LM7 cells resulted in visible metastatic lung nodules by 6-8 weeks. We quantified alphavbeta3 integrin expression using flow cytometry.
RESULTS: alphavbeta3 expression correlated with the metastatic potential of the cells, with LM7 cells showing the highest expression. LM7 cell adhesion to vitronectin decreased after treatment with echistatin, a RGD-containing peptide antagonist of alphavbeta3. LM7 cells demonstrated higher chemotactic activity than SAOS cells to a homogenate made from lung tissue. This chemotactic activity was also inhibited by echistatin. These data indicated that alphavbeta3 was critical for the migration of LM7 cells to the lung homogenate. Chemotaxis to a liver homogenate was the same for LM7 and SAOS cells. Migration of LM7 cells through lung endothelial cells was higher than that through liver endothelial cells, and echistatin again inhibited this migration.
CONCLUSIONS: alphavbeta3 integrin expression may play a role in the metastatic potential of osteosarcoma cells by enhancing the ability of the cells to migrate specifically to the lung. Alphavbeta3 integrin may therefore be a potential new target for osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16035619     DOI: 10.1007/s10585-005-0599-6

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  20 in total

1.  Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis.

Authors:  K Minamiguchi; H Kumagai; T Masuda; M Kawada; M Ishizuka; T Takeuchi
Journal:  Int J Cancer       Date:  2001-08-01       Impact factor: 7.396

Review 2.  Interactions between cancer cells and the endothelium in metastasis.

Authors:  F W Orr; H H Wang; R M Lafrenie; S Scherbarth; D M Nance
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 3.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

4.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

5.  Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase.

Authors:  E I Deryugina; M A Bourdon; K Jungwirth; J W Smith; A Y Strongin
Journal:  Int J Cancer       Date:  2000-04-01       Impact factor: 7.396

Review 6.  Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis.

Authors:  I J Fidler
Journal:  Surg Oncol Clin N Am       Date:  2001-04       Impact factor: 3.495

7.  A nude mouse model of human osteosarcoma lung metastases for evaluating new therapeutic strategies.

Authors:  S F Jia; L L Worth; E S Kleinerman
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

8.  Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.

Authors:  C C Kumar; M Malkowski; Z Yin; E Tanghetti; B Yaremko; T Nechuta; J Varner; M Liu; E M Smith; B Neustadt; M Presta; L Armstrong
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

Authors:  Robert R Langley; Karen M Ramirez; Rachel Z Tsan; Melissa Van Arsdall; Monique B Nilsson; Isaiah J Fidler
Journal:  Cancer Res       Date:  2003-06-01       Impact factor: 12.701

Review 10.  Cell adhesion receptor expression during melanoma progression and metastasis.

Authors:  I R Hart; M Birch; J F Marshall
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

View more
  25 in total

Review 1.  Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Robert E Brookover; Ryan M Garcia; Patrick J Getty; Edward M Greenfield
Journal:  Clin Orthop Relat Res       Date:  2008-07-08       Impact factor: 4.176

2.  Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells.

Authors:  Bian-Hong Fu; Ze-Zhi Wu; Jian Qin
Journal:  Mol Biol Rep       Date:  2009-09-21       Impact factor: 2.316

3.  The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.

Authors:  Xiaofei Chen; Joshua M Corbin; Greg J Tipton; Li V Yang; Adam S Asch; Maria J Ruiz-Echevarría
Journal:  Biochim Biophys Acta       Date:  2014-03-13

4.  Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models.

Authors:  Melinda Mata; Claudia Gerken; Phuong Nguyen; Giedre Krenciute; David M Spencer; Stephen Gottschalk
Journal:  Cancer Discov       Date:  2017-08-11       Impact factor: 39.397

5.  Targeting radioresistant osteosarcoma cells with parthenolide.

Authors:  Daniel Zuch; An-Hoa Giang; Yuriy Shapovalov; Edward Schwarz; Randy Rosier; Regis O'Keefe; Roman A Eliseev
Journal:  J Cell Biochem       Date:  2012-04       Impact factor: 4.429

6.  Effects of integrin α6β1 on migration of hepatocellular carcinoma cells.

Authors:  Bian-Hong Fu; Ze-Zhi Wu; Jian Qin
Journal:  Mol Biol Rep       Date:  2011-02-26       Impact factor: 2.316

7.  Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma.

Authors:  Daniel G Fuja; Nino C Rainusso; Ryan L Shuck; Lyazat Kurenbekova; Lawrence A Donehower; Jason T Yustein
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

8.  Vitronectin significantly influences prognosis in osteosarcoma.

Authors:  Kai Shi; Rui-Long Lan; Xuan Tao; Chao-Yang Wu; Hai-Feng Hong; Jian-Hua Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite.

Authors:  Shikhar Vohra; Kristin M Hennessy; Amber A Sawyer; Ya Zhuo; Susan L Bellis
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

10.  Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

Authors:  Nabil Ahmed; Vita S Salsman; Eric Yvon; Chrystal U Louis; Laszlo Perlaky; Winfried S Wels; Meghan K Dishop; Eugenie E Kleinerman; Martin Pule; Cliona M Rooney; Helen E Heslop; Stephen Gottschalk
Journal:  Mol Ther       Date:  2009-06-16       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.